Brain Metastases Articles & Analysis
12 news found
Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has released additional data related to the F-18 Pivalate (RAD 101) Phase 2a imaging trial in patients with brain metastases. ...
Food and Drug Administration (US FDA) clearance of the Investigational New Drug application (IND) for JBI-778, an oral, brain penetrant and selective protein arginine methyl transferase 5 (PRMT5) inhibitor, for the treatment of solid tumors with brain metastases and primary brain tumors including high-grade glioma. ...
Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. ...
ByxCures
.: 2547 Investigational 18F-fluciclovine presentation Category: Central Nervous System Session Title: 18F-Fluciclovine PET/CTto Distinguish Radiation Necrosis From Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery: Results of a Prospective Pilot Study* Presenter:Martin C. ...
Teoh has developed and progressed the Company’s brain metastases clinical program from inception to its current Phase 2/3 status. ...
Ondrej Choutka, MD, a neurosurgeon, and Lindsay Sales, MD, a radiation oncologist at Saint Alphonsus Regional Medical Center in Boise, have become the first doctors in the Pacific Northwest to utilize a new treatment for brain tumors. They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor. ...
"This grant will allow our team to analyze the role of immune-host cell interactions in defining different brain metastases patterns in non-small cell lung cancer (NSCLC)," said Professor Harriet Wikman, Ph.D., research scientist, University Hospital Hamburg-Eppendorf. "NSCLC accounts for about 85% of lung cancer cases, and the ability to further our research ...
It is the first medical device cleared for brain tumor treatment in the U.S. in the last ten years. "GammaTile Therapy improves the lives of patients with newly diagnosed malignant and recurrent brain tumors," said Matthew Likens, president and CEO of GT Medical Technologies, Inc. ...
Novocure has ongoing clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. ...
Sloan, the Director of the Brain Tumor Program. Over 400,000 patients are living with a brain tumor in the U.S. each year. ...
Sloan, the Director of the Brain Tumor Program. Over 400,000 patients are living with a brain tumor in the U.S. each year. ...
Data from the study will be used to benchmark clinical outcomes for GammaTile Therapy and allow for comparisons to existing standard-of-care treatments for patients with brain tumors. Over 700,000 Americans are living with a brain tumor today.1 Despite the efforts of the most skilled brain tumor specialists in the world, outcomes for patients ...